1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsLung Cell Biology is sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). This program from the NHLBI funds studies on lung cellular function, dysfunction, and disease mechanisms.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Advancing Heart, Lung, Blood, and Sleep Research & Innovation | NHLBI, NIH Leading the prevention and treatment of heart, lung, blood, and sleep disorders Health Education Resources What's Happening at the NHLBI To the rescue: Drones could deliver defibrillators for out-of-hospital cardiac arrests Learn tips to manage your pain with sickle cell disease Watch this video to learn about blood donation and how it can save lives Sickle cell disease causes the red blood cells to have a sickle or crescent shape instead of a disc shape.
The sickle-shaped cells can block blood vessels and lead to serious health problems. View Sickle Cell Disease Health Topic Featured Areas of Research Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions. NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
Heart Failure Research at NHLBI BioData Catalyst is a cloud-based ecosystem where researchers can analyze data related to NHLBI focus areas, like Long COVID, sickle cell disease, asthma, and heart disease. BioData Catalyst Research The goal of NHLBI-supported asthma research has been to discover better prevention and treatment options.
NHLBI Obesity, Nutrition, and Physical Activity (ONPA) Seminar Series: GLP-1 Receptor Agonists and Pregnancy Research That Heals: Partnering with Patients to Transform SCD Care The NHLBI has materials for patients and health professionals on many health topics, such as asthma, heart disease, and sickle cell disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives. Learn More About the NHLBI Mission and Strategic Vision Divisions, Offices, and Centers David C. Goff, M.
D. , Ph. D.
Meet the NHLBI Acting Director
According to the current listing, eligibility includes: Not explicitly stated in available snippets but typically includes academic institutions, non-profits, and other research organizations. Confirm the full requirements in the official notice before applying.
Lung Cell Biology is funded by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). This funding opportunity invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. The purpose is to engage small businesses in developing technologies and products that engage, empower, and motivate individuals and communities, including providers and healthcare institutions, to improve minority health and eliminate health disparities. This can include mobile health and telehealth technologies, and promoting big data science or enhancing data scientist training to address health inequities.
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). Provides funding to small businesses to bridge the gap between Phase II and commercialization for heart, lung, blood, and sleep disorder technologies.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article